Pretransplant clinicopathological correlation in end-stage primary pulmonary hypertension.

The aim of the study was to see if there was any correlation between the histopathology, ultrastructure, pulmonary endocrinology and clinical manifestations of end-stage primary pulmonary hypertension. Twenty patients undergoing heart-lung transplantation for the disease were studied. The nature and duration of symptoms and signs, results of haematological, electrocardiographic, radiographic, echocardiographic and haemodynamic studies, and the response of patients to vasodilators were compared with data from histopathological and ultrastructural study of lungs removed at transplantation. Length of clinical history and clinical evidence of severe disease were not necessarily associated with advanced histopathology, nor did the presence of small, contracted muscular pulmonary arteries imply responsiveness to vasodilators. Numbers of gastrin-releasing peptide-containing pulmonary endocrine cells were greater in lungs in which there was activity of myofibroblasts in pulmonary arterial vessels, and correlated negatively with mean pulmonary artery pressure and pulmonary artery systolic pressure. Whereas the prognosis of primary pulmonary hypertension cannot as yet be defined by other than its clinical manifestations, intimal proliferation as well as vasoconstriction may be important in its pathogenesis. The release of gastrin-releasing peptide from pulmonary endocrine cells may possibly be involved in this process.

[1]  M. Yacoub,et al.  The histopathology of 36 cases of plexogenic pulmonary arteriopathy , 1990, Histopathology.

[2]  J. Gosney Pulmonary Endocrine Pathology: Endocrine Cells and Endocrine Tumours of the Lung , 1992 .

[3]  J. Gosney,et al.  Ultrastructure of early plexogenic pulmonary arteriopathy , 1988, Histopathology.

[4]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[5]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[6]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[7]  M. Yacoub,et al.  Pulmonary endocrine cells in pulmonary arterial disease. , 1989, Archives of pathology & laboratory medicine.

[8]  F S Fay,et al.  Contraction of isolated smooth-muscle cells--structural changes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Yacoub,et al.  Pulmonary endocrine cells in hypertensive pulmonary vascular disease , 1990, Histopathology.

[10]  B. Madden,et al.  The ultrastructure of plexogenic pulmonary arteriopathy , 1990, The Journal of pathology.

[11]  J. Edwards,et al.  The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.

[12]  D. Buff Primary pulmonary hypertension. , 1987, Annals of internal medicine.

[13]  M. Yacoub,et al.  The pathology of the early and late stages of primary pulmonary hypertension. , 1987, British heart journal.

[14]  T. Higenbottam,et al.  Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). , 1987, British heart journal.